During the winter, you may struggle to feel warm no matter how much you bundle up. But some people actually break out in ...

Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...

Here are the top 5 AJMC.com articles and videos on allergy for 2025.

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...

Doctors call it "urticaria," but everyone else calls it "hives." We're talking about the incredibly itchy, swollen rash that can suddenly show up on skin, without warning, only to disappear and show ...

Dogs love treats! These delicious tidbits are a great way to reward good behavior, reinforce training, and show our dogs a little extra love. But not all dog treats are created equal. Many popular ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) is one of the best small cap stocks to buy with huge upside potential. Barclays ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung ...

The FDA approved a new 300 mg/2 mL dose of Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of four allergic and ...